Evogene Ltd. and CBD Technologies Ltd., a Challenge Fund II portfolio company, a wholly owned subsidiary of FuturaGene to collaborate on the improvement of cotton fiber properties. Under the agreement signed between the parties, CBD Technologies gains rights in cotton to certain promoters discovered by Evogene for evaluation in CBD Technologies' research & development program. The promoters were discovered by Evogene utilizing its in-silico gene discovery platform, the "ATHLETE".

Cotton fiber is constituted of  100% cellulose. As CBD Technologies' cell wall modifying technology has shown demonstrable cellulose polymer and fiber improvement in tree species, this collaboration is aimed at combining Evogene's promoters with CBD Technologies' cell wall modifying genes in order to enhance cotton fiber properties.